Article Details
Retrieved on: 2024-04-03 08:23:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the potential of biotech companies Ginkgo Bioworks and Agenus, as analyzed by The Motley Fool, highlighting their possible stock market growth despite recent decreases in value and uncertainties in revenue generation and drug development success.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here